STAT3 and neoplasm: Considering that the classic STAT3 trigger point of the immune system was also a significant signal in bone homeostasis (Li, 2013; Yang et al., 2019), we had good reason to be concerned that long-time anti-tumor treatment with Napabucasin would also affect the skeletal system of patients, which has never been reported to our knowledge.